المؤلفون: Aulifa DL; Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang Km. 21, Bandung 45363, Indonesia.; Study Center for Development of Pharmaceutical Preparations, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang Km. 21, Bandung 45363, Indonesia., Amirah SR; Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang Km. 21, Bandung 45363, Indonesia., Rahayu D; Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang Km. 21, Bandung 45363, Indonesia., Megantara S; Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang Km. 21, Bandung 45363, Indonesia., Muchtaridi M; Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang Km. 21, Bandung 45363, Indonesia.

المصدر: Molecules (Basel, Switzerland) [Molecules] 2024 Jun 23; Vol. 29 (13). Date of Electronic Publication: 2024 Jun 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE

مواضيع طبية MeSH: Angelica*/chemistry , Molecular Docking Simulation* , Hydroxymethylglutaryl CoA Reductases*/metabolism , Hydroxymethylglutaryl CoA Reductases*/chemistry, Hydroxymethylglutaryl-CoA Reductase Inhibitors/chemistry ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Secondary Metabolism ; Protein Binding ; Plant Extracts/chemistry ; Plant Extracts/pharmacology ; Ligands ; Pharmacophore

المؤلفون: Kondo S; Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan., Kurihara M; Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan., Higashihara M; Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan., Hara M; Department of Neuropathology (Brain Bank for Aging Research), Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan., Nishina Y; Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan., Iwakiri R; Department of Geriatrics, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan., Murayama S; Department of Neuropathology (Brain Bank for Aging Research), Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan., Saito Y; Department of Neuropathology (Brain Bank for Aging Research), Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan., Iwata A; Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.

المصدر: Geriatrics & gerontology international [Geriatr Gerontol Int] 2024 Jul; Vol. 24 (7), pp. 739-742. Date of Electronic Publication: 2024 Jun 11.

نوع المنشور: Case Reports; Journal Article; Letter

بيانات الدورية: Publisher: Japan Geriatrics Society Country of Publication: Japan NLM ID: 101135738 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1447-0594 (Electronic) Linking ISSN: 14470594 NLM ISO Abbreviation: Geriatr Gerontol Int Subsets: MEDLINE

مواضيع طبية MeSH: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Muscular Diseases*/drug therapy , Muscular Diseases*/chemically induced , Muscular Diseases*/immunology , Muscular Diseases*/diagnosis, Humans ; Female ; Aged, 80 and over ; Necrosis ; Glucocorticoids/administration & dosage ; Glucocorticoids/therapeutic use ; Administration, Oral ; Hydroxymethylglutaryl CoA Reductases/immunology

المؤلفون: Narayanan B; Department of Biochemistry, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA., Xia C; Department of Chemistry and Biochemistry, College of Arts and Sciences, University of North Florida, Jacksonville, FL, 32224, USA., McAndrew R; Department of Biochemistry, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA.; Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA, 94740, USA., Shen AL; McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, WI, 53706, USA., Kim JP; Department of Biochemistry, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA. jjkim@mcw.edu.

المصدر: Scientific reports [Sci Rep] 2024 Jun 05; Vol. 14 (1), pp. 12976. Date of Electronic Publication: 2024 Jun 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Acyl-CoA Dehydrogenase, Long-Chain*/metabolism , Acyl-CoA Dehydrogenase, Long-Chain*/genetics , Acyl-CoA Dehydrogenase, Long-Chain*/chemistry , Models, Molecular*, Substrate Specificity ; Humans ; Crystallography, X-Ray ; Catalytic Domain ; Acyl-CoA Dehydrogenases/metabolism ; Acyl-CoA Dehydrogenases/genetics ; Acyl-CoA Dehydrogenases/chemistry ; Protein Conformation ; Amino Acid Sequence

المؤلفون: Xu G; Department of Radiation Oncology, Mays Cancer Center at UT Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA.; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA., Quan S; Department of Radiation Oncology, Robert Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Schell J; Department of Radiation Oncology, Mays Cancer Center at UT Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA.; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA., Gao Y; Department of Radiation Oncology, Robert Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Varmazyad M; Department of Radiation Oncology, Mays Cancer Center at UT Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA.; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA., Sreenivas P; Department of Radiation Oncology, Mays Cancer Center at UT Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA.; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA., Cruz D; Department of Radiation Oncology, Mays Cancer Center at UT Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA.; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA., Jiang H; Department of Radiation Oncology, Mays Cancer Center at UT Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA.; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA., Pan M; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA., Han X; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA., Palavicini JP; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA.; Division of Diabetes, UT Health San Antonio, San Antonio, TX, USA., Zhao P; Department of Biochemistry and Structural Biology, UT Health San Antonio, San Antonio, TX, USA., Sun X; Department of Pharmacology, Mays Cancer Center, Transplant Center, UT Health San Antonio, San Antonio, TX, USA., Marchant ED; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA.; Department of Biochemistry and Structural Biology, UT Health San Antonio, San Antonio, TX, USA., Rasmussen BB; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA.; Department of Biochemistry and Structural Biology, UT Health San Antonio, San Antonio, TX, USA., Li G; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA., Katsumura S; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA.; Department of Molecular Medicine, UT Health San Antonio, San Antonio, TX, USA., Morita M; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA.; Department of Molecular Medicine, UT Health San Antonio, San Antonio, TX, USA.; Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe), Osaka University, Suita, Osaka 565-0871, Japan., Munkácsy E; Department of Radiation Oncology, Mays Cancer Center at UT Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA.; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA., Horikoshi N; Department of Radiation Oncology, Mays Cancer Center at UT Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA.; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA., Chocron ES; Department of Radiation Oncology, Mays Cancer Center at UT Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA.; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA., Gius D; Department of Radiation Oncology, Mays Cancer Center at UT Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA.; Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX, USA.

المصدر: Science advances [Sci Adv] 2024 May 17; Vol. 10 (20), pp. eadj5942. Date of Electronic Publication: 2024 May 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

مواضيع طبية MeSH: Non-alcoholic Fatty Liver Disease*/metabolism , Non-alcoholic Fatty Liver Disease*/genetics , Non-alcoholic Fatty Liver Disease*/pathology , Cellular Senescence*/genetics , Mitochondria*/metabolism , Stearoyl-CoA Desaturase*/metabolism , Stearoyl-CoA Desaturase*/genetics, Animals ; Mice ; Acetylation ; Male ; Acetate-CoA Ligase/metabolism ; Acetate-CoA Ligase/genetics ; Gene Knock-In Techniques ; Liver/metabolism ; Liver/pathology ; Lipid Metabolism ; Sirtuin 3/metabolism ; Sirtuin 3/genetics ; Disease Models, Animal ; Coenzyme A Ligases ; Fatty Acid Synthase, Type I

المؤلفون: Li J; The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 518033, China.; Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, 518033, China., Yang Z; Jinan University School of Traditional Chinese Medicine, Guangzhou, Guangdong, 510632, China., Wang T; The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 518033, China.; Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, 518033, China., Li M; Department of Nutrition and Food Hygiene, School of Public Health, Wuhan University, Wuhan, 430071, China., Wu X; The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 518033, China.; Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, 518033, China., Fu X; The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 518033, China.; Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, 518033, China., Yang C; The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 518033, China.; Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, 518033, China., Li Y; The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 518033, China.; Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, 518033, China., Wang X; The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 518033, China.; Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, 518033, China., Lan Z; The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 518033, China.; Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, 518033, China., Li M; The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 518033, China.; Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, 518033, China., Chen S; The fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 518033, China. szzyycs@126.com.; Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, 518033, China. szzyycs@126.com.

المصدر: BMC cancer [BMC Cancer] 2024 May 31; Vol. 24 (1), pp. 667. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Uterine Cervical Neoplasms*/genetics , Uterine Cervical Neoplasms*/drug therapy , Mendelian Randomization Analysis* , Hydroxymethylglutaryl CoA Reductases*/genetics , Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/drug therapy , Genome-Wide Association Study* , Proprotein Convertase 9*/genetics, Humans ; Female ; Hypolipidemic Agents/therapeutic use ; Hypolipidemic Agents/adverse effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Polymorphism, Single Nucleotide

المؤلفون: Göbel A; Mildred Scheel Early Career Center, Division of Endocrinology and Metabolic Bone Diseases, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; Center for Healthy Ageing, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: andy.goebel@ukdd.de., Pählig S; Mildred Scheel Early Career Center, Division of Endocrinology and Metabolic Bone Diseases, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; Center for Healthy Ageing, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany., Motz A; Mildred Scheel Early Career Center, Division of Endocrinology and Metabolic Bone Diseases, Department of Medicine III, Technische Universität Dresden, Dresden, Germany., Breining D; Mildred Scheel Early Career Center, Division of Endocrinology and Metabolic Bone Diseases, Department of Medicine III, Technische Universität Dresden, Dresden, Germany., Traikov S; Max Planck Institute for Molecular Cell Biology and Genetics, Dresden, Germany., Hofbauer LC; Mildred Scheel Early Career Center, Division of Endocrinology and Metabolic Bone Diseases, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; Center for Healthy Ageing, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany., Rachner TD; Mildred Scheel Early Career Center, Division of Endocrinology and Metabolic Bone Diseases, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; Center for Healthy Ageing, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.

المصدر: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 May 28; Vol. 710, pp. 149841. Date of Electronic Publication: 2024 Mar 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2104 (Electronic) Linking ISSN: 0006291X NLM ISO Abbreviation: Biochem Biophys Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacology , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/genetics , Acyl Coenzyme A*, Male ; Humans ; Hydroxymethylglutaryl CoA Reductases/genetics ; Hydroxymethylglutaryl CoA Reductases/metabolism ; Sterol Regulatory Element Binding Protein 1 ; Simvastatin/pharmacology ; Caspases ; Dipyridamole

المؤلفون: Ding W; The Second Clinical Medical School, Anhui University of Chinese Medicine, Hefei, Anhui, China., Chen L; Department of Gastroenterology, The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China., Xia J; Department of Gastroenterology, The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China., Pei B; The Second Clinical Medical School, Anhui University of Chinese Medicine, Hefei, Anhui, China., Song B; Department of Gastroenterology, The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China., Li X; Department of Gastroenterology, The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China.

المصدر: Medicine [Medicine (Baltimore)] 2024 May 03; Vol. 103 (18), pp. e38010.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

مواضيع طبية MeSH: Mendelian Randomization Analysis* , Neoplasms*/genetics , Neoplasms*/epidemiology , Hydroxymethylglutaryl CoA Reductases*/genetics , Polymorphism, Single Nucleotide* , Proprotein Convertase 9*, Humans ; Female ; PCSK9 Inhibitors ; Hypolipidemic Agents/therapeutic use ; Male ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use

المؤلفون: Miao L; Department of Dermatology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Miao T; Guangzhou University of Chinese Medicine, Guangzhou, China., Zhang Y; Department of Dermatology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Hao J; Department of Dermatology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. haojin_cq@163.com.

المصدر: BMC cancer [BMC Cancer] 2024 May 17; Vol. 24 (1), pp. 602. Date of Electronic Publication: 2024 May 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/genetics , Melanoma*/drug therapy , Mendelian Randomization Analysis* , Skin Neoplasms*/genetics , Skin Neoplasms*/drug therapy , Proprotein Convertase 9*/genetics , Hydroxymethylglutaryl CoA Reductases*/genetics , Genome-Wide Association Study*, Humans ; Melanoma, Cutaneous Malignant ; Antibodies, Monoclonal, Humanized/therapeutic use ; Polymorphism, Single Nucleotide ; Membrane Transport Proteins/genetics ; Membrane Proteins/genetics ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Ezetimibe/therapeutic use ; Hypolipidemic Agents/therapeutic use ; Hypolipidemic Agents/pharmacology

المؤلفون: Trenque T; Reims University Hospitals, Regional Centre for Pharmacovigilance and Pharmacoepidemiology, 51092 Reims, France; University of Reims Champagne-Ardenne, Faculty of Medicine, EA 3797, 51095 Reims, France. Electronic address: ttrenque@chu-reims.fr., Hadjoudj J; Reims University Hospitals, Regional Centre for Pharmacovigilance and Pharmacoepidemiology, 51092 Reims, France., Trenque A; Reims University Hospitals, Regional Centre for Pharmacovigilance and Pharmacoepidemiology, 51092 Reims, France., Tralongo F; Reims University Hospitals, Regional Centre for Pharmacovigilance and Pharmacoepidemiology, 51092 Reims, France., Martin S; Reims University Hospitals, Regional Centre for Pharmacovigilance and Pharmacoepidemiology, 51092 Reims, France., Azzouz B; Reims University Hospitals, Regional Centre for Pharmacovigilance and Pharmacoepidemiology, 51092 Reims, France; University of Reims Champagne-Ardenne, Faculty of Medicine, EA 3797, 51095 Reims, France.

المصدر: Therapie [Therapie] 2024 May-Jun; Vol. 79 (3), pp. 365-370. Date of Electronic Publication: 2023 Jul 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Masson Country of Publication: France NLM ID: 0420544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1958-5578 (Electronic) Linking ISSN: 00405957 NLM ISO Abbreviation: Therapie Subsets: MEDLINE

مواضيع طبية MeSH: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects , Muscular Diseases*/chemically induced , Muscular Diseases*/epidemiology , Muscular Diseases*/pathology , Pharmacovigilance*, Humans ; Male ; Female ; Middle Aged ; Aged ; France/epidemiology ; Hydroxymethylglutaryl CoA Reductases/immunology ; Adult ; Adverse Drug Reaction Reporting Systems/statistics & numerical data ; Necrosis/chemically induced ; Databases, Factual ; Atorvastatin/adverse effects ; Aged, 80 and over

المؤلفون: Marks MP; Laboratorio de Células Madre/Stem Cells Lab (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Biología y Medicina Experimental, Vuelta de Obligado 2490, CP 1428, Ciudad Autónoma de Buenos Aires, Argentina., Giménez CA; Instituto de Ciencias Básicas y Medicina Experimental, Instituto Universitario del Hospital Italiano, Potosí 4265, C1199ACL, Buenos Aires, Argentina.; CASPR Biotech, Buenos Aires, Argentina.; CASPR Biotech, San Francisco, USA., Isaja L; Laboratorio de Investigación Aplicada a Las Neurociencias (LIAN), Fundación Para La Lucha Contra Las Enfermedades Neurológicas de La Infancia (FLENI), Ruta 9, Km 53, B1625, Buenos Aires, Escobar, Argentina., Vera MB; Laboratorio de Investigación Aplicada a Las Neurociencias (LIAN), Fundación Para La Lucha Contra Las Enfermedades Neurológicas de La Infancia (FLENI), Ruta 9, Km 53, B1625, Buenos Aires, Escobar, Argentina., Borzone FR; Laboratorio de Células Madre/Stem Cells Lab (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Biología y Medicina Experimental, Vuelta de Obligado 2490, CP 1428, Ciudad Autónoma de Buenos Aires, Argentina., Pereyra-Bonnet F; Instituto de Ciencias Básicas y Medicina Experimental, Instituto Universitario del Hospital Italiano, Potosí 4265, C1199ACL, Buenos Aires, Argentina.; CASPR Biotech, Buenos Aires, Argentina.; CASPR Biotech, San Francisco, USA., Romorini L; Laboratorio de Investigación Aplicada a Las Neurociencias (LIAN), Fundación Para La Lucha Contra Las Enfermedades Neurológicas de La Infancia (FLENI), Ruta 9, Km 53, B1625, Buenos Aires, Escobar, Argentina., Videla-Richardson GA; Laboratorio de Investigación Aplicada a Las Neurociencias (LIAN), Fundación Para La Lucha Contra Las Enfermedades Neurológicas de La Infancia (FLENI), Ruta 9, Km 53, B1625, Buenos Aires, Escobar, Argentina., Chasseing NA; Laboratorio de Células Madre/Stem Cells Lab (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Biología y Medicina Experimental, Vuelta de Obligado 2490, CP 1428, Ciudad Autónoma de Buenos Aires, Argentina.; Laboratorio de Inmunohematología, (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Biología y Medicina Experimental, Vuelta de Obligado 2490, CP 1428, Ciudad Autónoma de Buenos Aires, Argentina., Calvo JC; Laboratorio de Células Madre/Stem Cells Lab (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Biología y Medicina Experimental, Vuelta de Obligado 2490, CP 1428, Ciudad Autónoma de Buenos Aires, Argentina., Vellón L; Laboratorio de Células Madre/Stem Cells Lab (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Biología y Medicina Experimental, Vuelta de Obligado 2490, CP 1428, Ciudad Autónoma de Buenos Aires, Argentina. luciano.vellon@ibyme.conicet.gov.ar.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Feb 28; Vol. 150 (2), pp. 106. Date of Electronic Publication: 2024 Feb 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacology, Humans ; Female ; Hydroxymethylglutaryl CoA Reductases/genetics ; Hydroxymethylglutaryl CoA Reductases/metabolism ; Oxidoreductases ; Cholesterol